News
-
-
-
COMMUNIQUÉ DE PRESSE
Technip Energies First Quarter 2025 Financial Results
-
-
-
COMMUNIQUÉ DE PRESSE
Immuno-Oncology Results from Research Collaboration with Léon Bérard Cancer Center Presented at AACR Annual Meeting 2025
OSE Immunotherapeutics and Léon Bérard Cancer Center present a new gene expression signature for predicting clinical response to immune checkpoint at AACR Annual Meeting 2025 -
COMMUNIQUÉ DE PRESSE
Strong Q1 2025 financial results and integration gaining momentum
-
COMMUNIQUÉ DE PRESSE
FRIEDRICH VORWERK increases revenues in the first quarter by 73% to € 133 million and improves EBITDA margin by 5 percentage points to 13.7%
FRIEDRICH VORWERK boosts Q1 revenues by 73% to €133 million, with EBITDA margin up by 5 percentage points to 13.7%. Strong growth prospects and increased profitability noted -
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: ams-OSRAM AG: ams OSRAM delivers 16.4% adj. EBITDA at revenues of €820m in Q1 above guidance mid-point, confirms 2025 FCF outlook>€100m, considers strategic options for certain assets for deleveraging
ams-OSRAM AG reports 16.4% adj. EBITDA at €820m in Q1, confirms 2025 FCF outlook. Considers asset options for deleveraging and strategic growth. Quarterly financial update and industry dynamics revealed
